SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TELK -- Telik, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (264)3/28/2002 3:51:23 PM
From: Tomato  Read Replies (2) of 887
 
I thought I'd look to see if there was an "ASCO effect" on the price of stocks with cancer drug prospects immediately prior and/or subsequent to ASCO (in mid-May, right?). Here's what I came up with using some stocks with cancer links:

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

Here's the BTK.X as a benchmark:

siliconinvestor.com

Not sure that I see much correlation. But TELK has the phase II results coming out in May, isn't it?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext